Technical and policy approaches to balancing patient privacy and data sharing in clinical and translational research

Bradley Malin, David Karp, Richard H. Scheuermann

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Introduction: Clinical researchers need to share data to support scientific validation and information reuse and to comply with a host of regulations and directives from funders. Various organizations are constructing informatics resources in the form of centralized databases to ensure reuse of data derived from sponsored research. The widespread use of such open databases is contingent on the protection of patient privacy. Methods: We review privacy-related problems associated with data sharing for clinical research from technical and policy perspectives. We investigate existing policies for secondary data sharing and privacy requirements in the context of data derived from research and clinical settings. In particular, we focus on policies specified by the US National Institutes of Health and the Health Insurance Portability and Accountability Act and touch on how these policies are related to current and future use of data stored in public database archives. We address aspects of data privacy and identifiability from a technical, although approachable, perspective and summarize how biomedical databanks can be exploited and seemingly anonymous records can be reidentified using various resources without hacking into secure computer systems. Results: We highlight which clinical and translational data features, specified in emerging research models, are potentially vulnerable or exploitable. In the process, we recount a recent privacy-related concern associated with the publication of aggregate statistics from pooled genome-wide association studies that have had a significant impact on the data sharing policies of National Institutes of Health-sponsored databanks. Conclusion: Based on our analysis and observations we provide a list of recommendations that cover various technical, legal, and policy mechanisms that open clinical databases can adopt to strengthen data privacy protection as they move toward wider deployment and adoption.

Original languageEnglish (US)
Pages (from-to)11-18
Number of pages8
JournalJournal of Investigative Medicine
Volume58
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Translational Medical Research
Information Dissemination
Privacy
Databases
Data privacy
National Institutes of Health (U.S.)
Health
Health insurance
Research
Health Insurance Portability and Accountability Act
Computer Security
Informatics
Computer systems
Genes
Genome-Wide Association Study
Computer Systems
Statistics
Publications
Research Personnel
Organizations

Keywords

  • Clinical research
  • Databases
  • Privacy
  • Translational research

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Technical and policy approaches to balancing patient privacy and data sharing in clinical and translational research. / Malin, Bradley; Karp, David; Scheuermann, Richard H.

In: Journal of Investigative Medicine, Vol. 58, No. 1, 01.2010, p. 11-18.

Research output: Contribution to journalArticle

@article{a1cd8d6bffcc48e9a9ac10ff267ade0d,
title = "Technical and policy approaches to balancing patient privacy and data sharing in clinical and translational research",
abstract = "Introduction: Clinical researchers need to share data to support scientific validation and information reuse and to comply with a host of regulations and directives from funders. Various organizations are constructing informatics resources in the form of centralized databases to ensure reuse of data derived from sponsored research. The widespread use of such open databases is contingent on the protection of patient privacy. Methods: We review privacy-related problems associated with data sharing for clinical research from technical and policy perspectives. We investigate existing policies for secondary data sharing and privacy requirements in the context of data derived from research and clinical settings. In particular, we focus on policies specified by the US National Institutes of Health and the Health Insurance Portability and Accountability Act and touch on how these policies are related to current and future use of data stored in public database archives. We address aspects of data privacy and identifiability from a technical, although approachable, perspective and summarize how biomedical databanks can be exploited and seemingly anonymous records can be reidentified using various resources without hacking into secure computer systems. Results: We highlight which clinical and translational data features, specified in emerging research models, are potentially vulnerable or exploitable. In the process, we recount a recent privacy-related concern associated with the publication of aggregate statistics from pooled genome-wide association studies that have had a significant impact on the data sharing policies of National Institutes of Health-sponsored databanks. Conclusion: Based on our analysis and observations we provide a list of recommendations that cover various technical, legal, and policy mechanisms that open clinical databases can adopt to strengthen data privacy protection as they move toward wider deployment and adoption.",
keywords = "Clinical research, Databases, Privacy, Translational research",
author = "Bradley Malin and David Karp and Scheuermann, {Richard H.}",
year = "2010",
month = "1",
doi = "10.231/JIM.0b013e3181c9b2ea",
language = "English (US)",
volume = "58",
pages = "11--18",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Technical and policy approaches to balancing patient privacy and data sharing in clinical and translational research

AU - Malin, Bradley

AU - Karp, David

AU - Scheuermann, Richard H.

PY - 2010/1

Y1 - 2010/1

N2 - Introduction: Clinical researchers need to share data to support scientific validation and information reuse and to comply with a host of regulations and directives from funders. Various organizations are constructing informatics resources in the form of centralized databases to ensure reuse of data derived from sponsored research. The widespread use of such open databases is contingent on the protection of patient privacy. Methods: We review privacy-related problems associated with data sharing for clinical research from technical and policy perspectives. We investigate existing policies for secondary data sharing and privacy requirements in the context of data derived from research and clinical settings. In particular, we focus on policies specified by the US National Institutes of Health and the Health Insurance Portability and Accountability Act and touch on how these policies are related to current and future use of data stored in public database archives. We address aspects of data privacy and identifiability from a technical, although approachable, perspective and summarize how biomedical databanks can be exploited and seemingly anonymous records can be reidentified using various resources without hacking into secure computer systems. Results: We highlight which clinical and translational data features, specified in emerging research models, are potentially vulnerable or exploitable. In the process, we recount a recent privacy-related concern associated with the publication of aggregate statistics from pooled genome-wide association studies that have had a significant impact on the data sharing policies of National Institutes of Health-sponsored databanks. Conclusion: Based on our analysis and observations we provide a list of recommendations that cover various technical, legal, and policy mechanisms that open clinical databases can adopt to strengthen data privacy protection as they move toward wider deployment and adoption.

AB - Introduction: Clinical researchers need to share data to support scientific validation and information reuse and to comply with a host of regulations and directives from funders. Various organizations are constructing informatics resources in the form of centralized databases to ensure reuse of data derived from sponsored research. The widespread use of such open databases is contingent on the protection of patient privacy. Methods: We review privacy-related problems associated with data sharing for clinical research from technical and policy perspectives. We investigate existing policies for secondary data sharing and privacy requirements in the context of data derived from research and clinical settings. In particular, we focus on policies specified by the US National Institutes of Health and the Health Insurance Portability and Accountability Act and touch on how these policies are related to current and future use of data stored in public database archives. We address aspects of data privacy and identifiability from a technical, although approachable, perspective and summarize how biomedical databanks can be exploited and seemingly anonymous records can be reidentified using various resources without hacking into secure computer systems. Results: We highlight which clinical and translational data features, specified in emerging research models, are potentially vulnerable or exploitable. In the process, we recount a recent privacy-related concern associated with the publication of aggregate statistics from pooled genome-wide association studies that have had a significant impact on the data sharing policies of National Institutes of Health-sponsored databanks. Conclusion: Based on our analysis and observations we provide a list of recommendations that cover various technical, legal, and policy mechanisms that open clinical databases can adopt to strengthen data privacy protection as they move toward wider deployment and adoption.

KW - Clinical research

KW - Databases

KW - Privacy

KW - Translational research

UR - http://www.scopus.com/inward/record.url?scp=74249091457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74249091457&partnerID=8YFLogxK

U2 - 10.231/JIM.0b013e3181c9b2ea

DO - 10.231/JIM.0b013e3181c9b2ea

M3 - Article

C2 - 20051768

AN - SCOPUS:74249091457

VL - 58

SP - 11

EP - 18

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 1

ER -